Altria stock slid more than 8% on Wednesday following a report that the FDA plans to order Juul to pull its electronic cigarettes off the market in the US — posing big risks for the tobacco giant’s investment in the vaping startup.
The move by the FDA could be announced as soon as Wednesday, said the Wall Street Journal. Altria and Juul did not immediately respond to requests for comment.
The decision comes just a day after the FDA announced intent to require tobacco makers to reduce the amount of nicotine in their products to nonaddictive levels. Any action on that front is likely at least a year away.
Meanwhile, the FDA is attempting to determine whether vaping products from hundreds of companies can still be sold, after asking manufacturers of those products to submit applications demonstrating their products were healthier than traditional cigarettes.
However, the FDA last year held off on making the call on Juul’s products.
Altria, best known for selling Marlboro cigarettes in the US, in 2018 said it would take a 35% stake in Juul. But Juul has faced lawsuits alleging misleading health claims, along with allegations it was trying to draw younger consumers to vaping.
Unexpected Move, Altria Stock Responds
The potential decision by the FDA comes as Altria tries to become less of a traditional-cigarette company, focusing more on devices that don’t produce smoke. However, the company still gets 85% of its profit from those products, Cowen says.
The news drove Altria stock to undercut a December low, leaving shares at their lowest level since January 2021.
“MO’s shares are trading down on the news, which is expected, as JUUL was a key piece of the company’s reduced risk strategy,” Cowen analyst Vivien Azer said in a note on Wednesday. “We expect the company to appeal, with the products remaining on the market.”
But she said the decision was unexpected. She said she thought Juul could get limited approvals for some tobacco-flavored vapes, “given that the FDA has acknowledged the role of e-cigs as part of a broader harm reduction strategy, including the implementation of a nicotine cap.”
The FDA on Tuesday announced plans to propose a measure that would set maximum limits on nicotine in cigarettes. The agency said it hoped the potential rule would reduce cigarette usage among youths. In 2020, the agency banned many flavored cartridge-based vapes, save for tobacco and menthol.
In February, a judge, in an initial decision, dismissed the Federal Trade Commission’s antitrust charges against Altria’s investment in Juul. The agency in 2020 sued to unwind Altria’s stake.
Altria stock has a 78 Composite Rating. Its EPS Rating is 76.
MO stock plunged 8.4% to 41.50, hitting a 16-month low.
Among other tobacco stocks, Philip Morris International (PM) lost 0.9%. British American Tobacco (BTI) fell 1.3%.
YOU MAY ALSO LIKE:
Recession Rules: Do’s And Don’ts
See Stocks On The List Of Market Leaders With IBD Leaderboard
IBD 50 Stocks To Watch: Health Care Stock Tops Buy Point, But There’s A Downside
9 Big Companies Already Plunged Into A Recession, Analysts Say
Market Rally Seeks Direction; Five Stocks From Hot Sector